Skip to main content

Medtronic Value Stock - Dividend - Research Selection

Medtronic

ISIN: IE00BTN1Y115 , WKN: A14M2J

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Medtronic plc manufactures and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company\'s Cardiac and Vascular Group segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; diagnostics and monitoring devices; mechanical circulatory support, TYRX, and AF products; and remote monitoring and patient-centered software. It also provides transcatheter heart valves, percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment offers surgical care, wound closure, electrosurgical, hernia mechanical device, mesh implant, ablation, interventional lung, ventilator, capnography, airway, sensor, monitor, compression, dialysis, enteral feeding, wound care, and medical surgical products; stapling, vessel sealing, fixation, and hardware instruments; and gastrointestinal, temperature management, inhalation therapy, and renal care solutions. The company\'s Restorative Therapies Group segment offers products for spine, bone graft substitutes, biologic products, trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis, as well as products to treat conditions of the ear, nose, and throat; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems; and therapies for vasculature in and around the brain. The company\'s Diabetes Group segment offers insulin pumps and consumables, continuous glucose monitoring systems, and Web-based therapy management software. The company was founded in 1949 and is headquartered in Dublin, Ireland.
The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


BDJ: This Covered Call And Dividend Income Fund Is Solid, Just Watch The Price

2023-02-28
BDJ looks a little expensive right now, which is the only thing wrong with it today. Click here to read more.

Medtronic Executive Vice President and CFO Karen Parkhill to speak at Cowen healthcare conference

2023-02-27
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual Cowen healthcare conference on Monday, March 6, 2023.

Medtronic PLC stock outperforms competitors despite losses on the day

2023-02-27
Shares of Medtronic PLC sank 0.12% to $83.39 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...

Medtronic's (MDT) MiniMed 780G System Shows Favorable Results

2023-02-27
Medtronic's (MDT) MiniMed 780G system was designed to forecast real-life requirements where carbohydrate counts aren't always exact and meal doses are often missed.

Dividend Stocks To Buy Now? 3 For Your Watchlist

2023-02-27
Dividend stocks to watch this week.

Better Dividend Stock: Abbott Laboratories or Medtronic?

2023-02-27
Dividend stocks tend to outperform other asset classes during economically challenging times. The dividend powerhouses Abbott Laboratories (NYSE: ABT) and Medtronic (NYSE: MDT) apparently didn't get this memo, however. Despite both companies raising their dividends for over four straight decades, Abbott and Medtronic's shares actually sank faster than the broader markets over the course of 2022.

One Medtronic plc (NYSE:MDT) insider reduced their stake by 26% in the previous year

2023-02-26
Viewing insider transactions for Medtronic plc's ( NYSE:MDT ) over the last year, we see that insiders were net...

S&P 500 Dividend Aristocrats List: Sorted by Hedge Fund Popularity

2023-02-25
In this article, we will discuss the 15 S&P 500 dividend aristocrats popular among hedge funds. You can skip our detailed analysis of dividend stocks and their performance over the years, and go directly to read S&P 500 Dividend Aristocrats: Top 5 Among Hedge Funds. Investors are regaining confidence in the stock market as the […]

My Best Dividend Aristocrats For March 2023

2023-02-25
NOBL started the year off with a gain of 3.23% in January, it is thus far not fairing as well in February but the ETF is still positive YTD. Read more here.

Pharmas, medtechs dominate list of innovation leaders thanks to patents

2023-02-25
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.